Curis (CRIS) EBT Margin Growth (1y) (2011 - 2025)
Curis (CRIS) EBT Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
198,841.00 |
| Sep 30, 2025 |
10,096.00 |
| Jun 30, 2025 |
15,100.00 |
| Mar 31, 2025 |
12,327.00 |
| Dec 31, 2024 |
14,689.00 |
| Sep 30, 2024 |
8,565.00 |
| Jun 30, 2024 |
8,083.00 |
| Mar 31, 2024 |
-6,610.00 |
| Dec 31, 2023 |
-4,201.00 |
| Sep 30, 2023 |
4,062.00 |
| Jun 30, 2023 |
12,169.00 |
| Mar 31, 2023 |
27,991.00 |
| Dec 31, 2022 |
4,204.00 |
| Sep 30, 2022 |
-10,694.00 |
| Jun 30, 2022 |
-15,307.00 |
| Mar 31, 2022 |
-32,964.00 |
| Dec 31, 2021 |
-18,587.00 |
| Sep 30, 2021 |
-14,577.00 |
| Jun 30, 2021 |
-22,876.00 |
| Mar 31, 2021 |
-9,432.00 |
